Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing.

We support a large global customer base which includes hospitals to large corporates. Our proprietary technology platform NOVAPREP® is a unique next generation liquid based cytology solution focused on cancer management.

Type
Public
HQ
Vélizy Villacoublay, FR
Size (employees)
67 (est)
Novacyt is headquartered in Vélizy-Villacoublay, FR

Novacyt Office Locations

Novacyt has offices in Vélizy-Villacoublay and Milton
Vélizy-Villacoublay, FR (HQ)
13 Avenue Morane Saulnier
Milton, GB
Winship Rd

Novacyt Financials and Metrics

Novacyt Financials

EUR

Market capitalization (17-Oct-2017)

11.9 m

Closing share price (17-Oct-2017)

0.8
Novacyt's current market capitalization is €11.9 m.
Show all financial metrics

Novacyt Market Value History

Traffic Overview of Novacyt

Novacyt Company Life and Culture

You may also be interested in